Clinical trials
Observational trials in Finland with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
126 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 3 |
| 2015 | 8 |
| 2016 | 9 |
| 2017 | 9 |
| 2018 | 15 |
| 2019 | 8 |
| 2020 | 13 |
| 2021 | 10 |
| 2022 | 6 |
| 2023 | 11 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 126 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Turku University Hospital | 20 |
| Helsinki University Central Hospital | 19 |
| Tampere University Hospital | 16 |
| University of Oulu | 8 |
| University of Helsinki | 6 |
| University of Turku | 6 |
| Kuopio University Hospital | 4 |
| Hospital District of Helsinki and Uusimaa | 3 |
| Oulu University Hospital | 3 |
| Tampere University | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 6 |
| COVID-19 | 4 |
| Cardiovascular Diseases | 4 |
| Diabetes Mellitus | 4 |
| Diabetes Mellitus, Type 2 | 4 |
| Myocardial Infarction | 4 |
| Stroke | 4 |
| Aortic Valve Stenosis | 3 |
| Cognitive Dysfunction | 3 |
| Coronary Disease | 3 |
Trials
Showing 1 to 25 of 126. Each trial links to its page on Pharma Observatory.
26 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.